888 results on '"Vose, Julie M."'
Search Results
2. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
3. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
4. MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCL
5. Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
6. Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium
7. Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
8. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
9. 2024 Statistics May Impact Next Decade of Cancer Treatment
10. Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
11. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
12. Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
13. Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
14. ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
15. Complementary and Alternative Medicine in Cancer Care: Does It Have a Role?
16. Electronic Medical Records and Physicians: A Love-Hate Relationship
17. Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics
18. Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma
19. 2023 Year in Review: Topics in Hematology/Oncology
20. Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial
21. CLL-217 Patient Characteristics and Time to Next Treatment With Ibrutinib and Anti-CD20 Monotherapy as First-Line Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
22. Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
23. Multidisciplinary Team Approach Is Integral to Oncology Care
24. Oligonucleotide Microarrays Demonstrate the Highest Frequency of ATM Mutations in the Mantle Cell Subtype of Lymphoma
25. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study
26. Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based Therapy
27. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma
28. 171 - Non-Hodgkin Lymphomas
29. An International Real-World Analysis of Relapsed/Refractory Lymphoma Occurring During Pregnancy
30. Hope After Salvage Therapy Fails: Novel Agents for Relapsed/Refractory Hodgkin Lymphoma
31. Care Plans, Education Improve Long-term Quality of Life
32. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database
33. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
34. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
35. LEAD 2022: Enriching Experiences for Women in Hematology & Oncology
36. Burnout: Which Way Out?
37. Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
38. Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades
39. Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation
40. Management of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
41. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
42. Early Failure of Frontline Rituximab-Containing Chemo-immunotherapy in Diffuse Large B Cell Lymphoma Does Not Predict Futility of Autologous Hematopoietic Cell Transplantation
43. A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20 + indolent NHL: Correlation between clinical responses and AUC pharmacokinetics
44. Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma
45. Chapter 86 - Mantle Cell Lymphoma
46. Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymphoma
47. American Society of Hematology: 64th Annual Meeting Review
48. ABCL-191 Extended Follow-Up Beyond 2.5 Years Demonstrates Long-Term Efficacy in Complete Responders Following Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)
49. Extended Follow-Up Beyond 2 .5 Years Demonstrates Long-Term Efficacy in Complete Responders Following Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)
50. Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T‐cell lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.